Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Panbela Therapeutics Inc. buy Roth Mkm

Panbela Therapeutics Inc.
Start price
€90.36
18.12.23 / 50%
Target price
€22.90
18.12.24
Performance (%)
-
End price
-
19.12.24
Summary
This prediction was cancelled by the user.
Performance without dividends (%)
Name 1w 1m 1y
Panbela Therapeutics Inc. - - -
iShares Core DAX® 3.002% 4.755% 23.700%
iShares Nasdaq 100 2.966% 0.363% 8.027%
iShares Nikkei 225® 5.606% 4.528% 20.313%
iShares S&P 500 2.312% 1.811% 5.451%

Comments by Roth_Mkm for this prediction

In the thread Panbela Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) -
Target price 22.900
Change
Ends at 18.12.24

Panbela Therapeutics, Inc. (NASDAQ: PBLA) had its "buy" rating re-affirmed by analysts at Roth Mkm. They now have a $25.00 price target on the stock.
Ratings data for PBLA provided by MarketBeat

Roth Mkm 
0
Report Share
18.12.23
In the thread Trading Panbela Therapeutics Inc.
Prediction Buy
Perf. (%) -
Target price 22.900
Change
Ends at 18.12.24

Die von Roth_Mkm gewählte maximale Laufzeit wurde überschritten

Roth Mkm 
0
Report Share
19.12.24

Stopped prediction by Roth_Mkm for Panbela Therapeutics Inc.

buy
Panbela Therapeutics Inc.

Start price
Target price
Perf. (%)
€90.36
27.03.24
€23.10
27.03.25
-
28.03.25

Roth Mkm 
27.03.24 50%
buy
Panbela Therapeutics Inc.

Start price
Target price
Perf. (%)
€90.36
05.02.24
€23.26
05.02.25
-
06.02.25

Roth Mkm 
05.02.24 50%